Aurim Med Pharma
Pharmaceuticals, Po Box 980007, Park City, Utah, 84098, United States, 1-10 Employees
Phone Number: 43********
Who is AURIMMED PHARMA
AurimMed Pharma is a product-oriented, market-driven, and applied-science development-stage pharmaceutical company. AurimMed is developing small-molecule pharmaceutical products by using ...
Read More
-
Headquarters: Po Box 980007, Park City, Utah, 84098, United States
-
Date Founded: 2007
-
Employees: 1-10
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 999990 |
Show More
Does something look wrong? Fix it. | View contact records from AURIMMED PHARMA
AurimMed Pharma Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding AurimMed Pharma
Answer: AurimMed Pharma's headquarters are located at Po Box 980007, Park City, Utah, 84098, United States
Answer: AurimMed Pharma's phone number is 43********
Answer: AurimMed Pharma's official website is https://aurimmed.com
Answer: AurimMed Pharma's revenue is Under $1 Million
Answer: AurimMed Pharma's SIC: 2834
Answer: AurimMed Pharma's NAICS: 999990
Answer: AurimMed Pharma has 1-10 employees
Answer: AurimMed Pharma is in Pharmaceuticals
Answer: AurimMed Pharma contact info: Phone number: 43******** Website: https://aurimmed.com
Answer: AurimMed Pharma is a product-oriented, market-driven, and applied-science development-stage pharmaceutical company. AurimMed is developing small-molecule pharmaceutical products by using carefully selected privileged structures as lead compounds for proprietary product development. This rational, proven strategy greatly shortens product development times while enhancing clinical and commercial success. The company is currently developing compounds active in the Central Nervous System (CNS) such as novel anticonvulsants, analgesics (for neuropathic pain), and neuroprotective agents. Such CNS-active agents are also often useful in the treatment of anxiety, depression, insomnia, schizophrenia, Parkinsons disease, and bipolar disorder. The initial focus of AurimMed Pharma is the development of safe and effective drug products up through Phase I clinical trials. Upon completion of the initial trials, the Company intends to seek agreements with larger biopharmaceutical and/or large pharmaceutical companies in order to co-develop the products through Phase II/III clinical trials. Alternatively, the company would consider licensing the products to companies with existing marketing and business development infrastructure for the marketing of drug products.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month